French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding)

Thrombosis Research

Volumn 126, Issue 3, 2010, Pages

  Pernod, Gilles ^a   Godiér, Anne ^a   Gozalo, Claire ^a   Tremey, Benjamin ^a   Sié, Pierre ^a  

^a NONE

Author keywords

Guideline; Haemorrhage; Overdose; Vitamin K antagonists

Indexed keywords

ANTIVITAMIN K; PROTHROMBIN COMPLEX;

BLEEDING; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG OVERDOSE; DRUG USE; ELECTIVE SURGERY; EMERGENCY SURGERY; FRANCE; HUMAN; INTERNATIONAL NORMALIZED RATIO; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SHORT SURVEY;

EID: 77956268067     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.06.017     Document Type: Review

References (61)

1. V. Pengo, F. Barbero, A. Banzato, E. Garelli, F. Noventa, and A. Biasiolo A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses Thromb Haemost 77 1997 839 844
2. E.M. Hylek, A.S. Go, Y. Chang, N.G. Jensvold, L.E. Henault, and J.V. Selby Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation N Engl J Med 349 2003 1019 1026
3. M.C. Fang, Y. Chang, E.M. Hylek, J. Rosand, S.M. Greenberg, and A.S. Go Advanced age, anticoagulation intensity, and risk for intracranial haemorrhage among patients taking warfarin for atrial fibrillation Ann Intern Med 141 2004 745 752
4. M.W. Reynolds, K. Fahrbach, O. Hauch, G. Wygant, R. Estok, and C. Cella Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis Chest 126 2004 1938 1945
5. E.M. Hylek, S. Regan, G.O. AS, R.A. Hughes, D.E. Singer, and S.J. Skates Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin Ann Intern Med 135 2001 393 400
6. R.T. Weibert, D.T. Le, S.R. Kayser, and S.I. Rapaport Correction of excessive anticoagulation with low-dose oral vitamin K1 Ann Intern Med 126 1997 959 962
7. A. Lubetsky, H. Yonath, D. Olchovsky, R. Loebstein, H. Halkin, and D. Ezra Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study Arch Intern Med 163 2003 2469 2473
8. M.A. Crowther, W. Ageno, T. Schnurr, E. Manfredi, K. Kinnon, and D. Garcia Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin Haematologica 90 2005 137 139
9. K.J. DeZee, W.T. Shimeall, K.M. Douglas, N.M. Shumway, and P.G. O'malley Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis Arch Intern Med 166 2006 391 397
10. J. Ansell, J. Hirsh, E. Hylek, A. Jacobson, M. Crowther, and G. Palareti Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 160 198
11. Y.K. Kim, R. Nieuwlaat, S.J. Connolly, S. Shulman, K. Meijer, and N. Raju Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study J Thromb Haemost 8 2010 101 106
12. G. Denas, F. Marzot, P. Offelli, A. Stendardo, U. Cucchini, and R. Russo Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1, 043 cases J Thromb Thrombolysis 27 2009 340 347
13. M.A. Crowther, W. Ageno, D. Garcia, L. Wang, D.M. Witt, and N.P. Clark Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial Ann Intern Med 150 2009 293 300
14. P. Pouyanne, F. Haramburu, L. Imbs, and B. Begaud Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance centres Br Med J 320 2000 1036
15. C.S. Landefeld, E.F. Cook, M. Flatley, M. Weisberg, and L. Goldman Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy Am J Med 82 1987 703 713
16. C.S. Landefeld, and L. Goldman Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy Am J Med 87 1989 144 152
17. S.D. Fihn, M. McDonell, D. Martin, J. Henikoff, D. Vermes, and D. Kent Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group Ann Intern Med 118 1993 511 520
18. G. Palareti, J. Hirsh, C. Legnani, C. Manotti, A. D'Angelo, and V. Pengo Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study Arch Intern Med 160 2000 470 478
19. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihaemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
20. M. Yasaka, M. Oomura, K. Ikeno, H. Naritomi, and K. Minematsu Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication Ann Hematol 82 2003 121 123
21. H.B. Huttner, P.D. Schellinge, M. Hartmann, M. Köhrmann, E. Juettler, and J. Wikner Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates Stroke 37 2006 1465 1470
22. G. Evans, R. Luddington, and T. Baglin Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding Br J Haematol 115 2001 998 1001
23. A. Lubetsky, R. Hoffman, R. Zimlichman, A. Eldor, J. Zvi, and V. Kostenko Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation Thromb Res 113 2004 371 378
24. M. Yasaka, T. Sakata, H. Naritomi, and K. Minematsu Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation Thromb Res 115 2005 455 459
25. B. Vigue, B. Ract, and B. Tremey Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage Intensive Care Med 33 2007 721 725
26. M. Makris, M. Greaves, W.S. Phillips, S. Kitchen, F.R. Rosendaal, and E.F. Preston Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy Thromb Haemost 77 1997 477 480
27. N.M. Boulis, M.P. Bobek, A. Schmaier, and J.T. Hoff Use of factor IX complex in warfarin-related intracranial hemorrhage Neurosurgery 45 1999 1113 1118
28. M. Cartmill, G. Dolan, J.L. Byrne, and P.O. Birne Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies Br J Neurosurg 14 2000 458 461
29. J. Lin, W.C. Hanigan, M. Tarantino, and J. Wang The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings J Neurosurg 98 2003 737 740
30. W.E. Dager, J.H. King, R.C. Regalia, D. Williamson, R.C. Gosselin, and R.H. White Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin Pharmacotherapy 26 2006 1091 1098
31. A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, and G. Filippatos et al; Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur Heart J 28 2007 230 268
32. T. Steiner, M. Kaste, M. Forsting, D. Mendelow, H. Kwiecinski, and I. Szikora Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee Cerebrovasc Dis 22 2006 294 316
33. V.L. Babikian, C.S. Kase, M.S. Pessin, L.R. Caplan, and P.B. Gorelick Resumption of anticoagulation after intracranial bleeding in patients with prosthetic heart valves Stroke 19 1988 407 408
34. A.C. Butler, and R.C. Tait Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up Br J Haematol 103 1998 1064 1066
35. E.F. Wijdicks, W.I. Schievink, R.D. Brown, and C.J. Mullany The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves Neurosurgery 42 1998 769 773
36. O. Kovich, and C.C. Otley Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation J Am Acad Dermatol 48 2003 233 237
37. N. Kumar, S. JIvan, P. Thomas, and H. McLure Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel J Cataract Refract Surg 32 2006 1022 1025
38. B. Napoléon, B. Boneu, L. Maillard, C.M. Samama, J.F. Schved, and G. Gay Board of the French Society for Digestive Endoscopy (SFED). Guidelines of the French Society for Digestive Endoscopy (SFED) Endoscopy 38 2006 632 638
39. S.C. Cannegieter, F.R. Rosendaal, and E. Briet Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses Circulation 89 1994 635 641
40. J.H. Tinker, and S. Tarhan Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations JAMA 239 1978 738 739
41. A.S. Dunn, and A.G. Turpie Perioperative management of patients receiving oral anticoagulants: a systematic review Arch Intern Med 163 2003 901 908
42. D.A. Garcia, S. Regan, L.E. Henault, A. Upadhyay, J. Baker, and M. Othman Risk of Thromboembolism With Short-term Interruption of Warfar in Therapy Arch Int Med 168 2008 63 69
43. M.I. Aguilar, and R. Hart Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks Cochrane Database Syst Rev 3 2005 CD001927
44. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Randford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
45. R. Hull, T. Delmore, E. Genton, J. Hirsh, M. Gent, and D. Sackett Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis N Engl J Med 301 1979 855 858
46. M.N. Levine, J. Hirsh, M. Gent, A.G. Turpie, J. Weitz, and J. Ginsberg Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis Thromb Haemost 74 1995 606 611
47. C. Kearon, J.S. Ginsberg, D.R. Anderson, M. Kovacs, P. Wells, and J.A. Julian Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor J Thromb Haemost 2 2004 743 749
48. R.D. Hull, C.J. Carter, R.M. Jay, P.A. Ockelford, J. Hirsch, and A.G. Turpie The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge Circulation 67 1983 901 906
49. A. Steib, J. Barre, M. Mertes, M.H. Morel, N. Nathan, and Y. Ozier Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists? J Thromb Haemost 8 2010 499 503
50. A. Malato, G. Saccullo, L. Lo Coco, D. Caramazza, I. Abbene, and G. Pizzo Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin J Thromb Haemost 8 2010 107 113
51. T.P. Carrel, W. Klingenmann, P.J. Mohacsi, P. Berdat, and U. Althaus Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review J Heart Valve Dis 8 1999 392 398
52. J.A. Madura, M. Rookstool, and G. Wease The management of patients on chronic coumadin therapy undergoing subsequent surgical procedures Am Surg 60 1994 542 546
53. A.C. Spyropoulos, A.G. Turpie, A.S. Dunn, J. Spandorfer, J. Douketis, and A. Jacobson Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry J Thromb Haemost 4 2006 1246 1252
54. J.M. Spandorfer, S. Lynch, H.H. Weitz, S. Fertel, and G.J. Merli Use of enoxaparin for the chronically anticoagulated patient before and after procedures Am J Cardiol 84 1999 478 480
55. A.H. Tinmouth, B.H. Marrow, M.K. Cruickshank, P.M. Moore, and M.J. Kovacs Dalteparin as periprocedure anticoagulation for patients on warfarine and at high risk of thrombosis Ann Pharmacother 35 2001 669 674
56. S. Wilson, J.D. Douketis, and M.A. Crowther Treatment of warfarin-associated coagulopathy: a physician survey Chest 120 2001 1972 1976
57. J.D. Douketis, J.A. Johnson, and A.G. Turpie Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarine: assessment of a standardized periprocedural anticoagulation regimen Arch Intern Med 164 2004 1319 1326
58. M.J. Kovacs, C. Kearon, M. Rodger, D.R. Anderson, A.G. Turpie, and S.M. Bates Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin Circulation 21 2004 1518 1519
59. A.K. Jaffer, M. Ahmed, D.J. Brotman, L. Bragg, N. Seshadri, and M.A. Qadeer Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol J Thromb Thrombolysis 20 2005 11 16
60. V. Fuster, L.E. Rydén, D.S. Cannom, H.J. Crijns, and A.B. Curtis ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rythm Society Circulation 114 2006 e257 e354
61. K.S. Schick, J.M. Fertmann, K.W. Jauch, and J.N. Hoffmann Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding Crit Care 13 2009 1 15